Michael A. Sherman's Net Worth
$9.12 Million
Who is Michael A. Sherman?
Michael A. Sherman has an estimated net worth of $9.12 Million. This is based on reported shares across multiple companies, which include Mead Johnson Nutrition Co, CHIMERIX INC, Werewolf Therapeutics, Inc., BIOSPECIFICS TECHNOLOGIES CORP, and ENDOCYTE INC.
SEC CIK
Michael A. Sherman's CIK is 0001509463
Past Insider Trading and Trends
2018 was Michael A. Sherman's most active year for acquiring shares with 12 total transactions. Michael A. Sherman's most active month to acquire stocks was the month of January. 2018 was Michael A. Sherman's most active year for disposing of shares, totalling 28 transactions. Michael A. Sherman's most active month to dispose stocks was the month of November. 2018 saw Michael A. Sherman paying a total of $770,469.62 for 383,512 shares, this is the most they've acquired in one year. In 2018 Michael A. Sherman cashed out on 1,468,066 shares for a total of $26,622,265.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mead Johnson Nutrition Co No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.05K |
$90.00 | -$364,590.00 |
0
|
Jun 15
| |||
Form 4
| +141.42% | 2.37K |
—
|
—
| 4.05K |
Feb 28 - Mar 1
| |||
Form 4
|
∞
| 1.68K |
—
|
—
| 1.68K |
Feb 26 - Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHIMERIX INC (CMRX) Snapshot price: $0.9198
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 87K |
$1.12 | $97,651.69 | 87K |
May 12
| |||
Form 4
| +71.48% | 92.95K |
—
|
—
| 223K |
Jan 17
| |||
Form 4/A
| +394.26% | 100K |
$2.09 | $209,000.00 | 125.36K |
Jul 25
| |||
Form 4
| +394.26% | 100K |
$2.09 | $209,000.00 | 125.36K |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
| +243.32% | 73K |
$1.45 | $105,652.96 | 103K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
∞
| 30K |
$3.48 | $104,316.00 | 30K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Werewolf Therapeutics, Inc. (HOWL) Snapshot price: $6.31
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOSPECIFICS TECHNOLOGIES CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.02K |
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
∞
| 2.02K |
—
|
—
| 2.02K |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENDOCYTE INC No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -399.28K |
$24.00 | -$9,582,816.00 |
0
|
Dec 21
| |||
Form 4
| +9.04% | 31.45K |
$6.52 | $753,783.44 | 379.37K |
Dec 17
| |||
Form 4
| -7.48% | -28.15K |
$15.55 | -$437,751.92 | 347.92K |
Scheduled
|
Oct 5
| ||
Form 4
| +11.08% | 37.5K |
—
|
—
| 376.06K |
Feb 8
| |||
Form 4
| +1.64% | 5.45K |
$3.06 | $16,686.18 | 338.56K |
Feb 2
| |||
Form 4
| +60.06% | 125K |
—
|
—
| 333.11K |
Oct 4
| |||
Form 4
| +27.03% | 44.28K |
$2.10 | $92,998.50 | 208.11K |
May 31
| |||
Form 4
| -2.26% | -3.78K |
$2.18 | -$8,249.12 | 163.83K |
Feb 4 - Feb 6
| |||
Form 4
| +22.92% | 31.25K |
—
|
—
| 167.61K |
Feb 2
| |||
Form 4
| +7.91% | 10K |
—
|
—
| 136.36K |
Jun 16
| |||
Form 4
| +10.53% | 11.91K |
$3.13 | -$7,727.66 | 124.97K |
Feb 4 - Feb 6
| |||
Form 4
| +14.07% | 13.68K |
$5.14 | -$3,562.02 | 110.91K |
Feb 4 - Feb 6
| |||
Form 4
| +18.32% | 14.93K |
$2.48 | $36,972.70 | 96.39K |
Oct 31
| |||
Form 4
| +10.23% | 7.5K |
—
|
—
| 80.8K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
| +28.98% | 20.94K |
$1.98 | $41,491.29 | 93.22K |
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 4
| +38.05% | 19.92K |
—
|
—
| 72.28K |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||